Metabolomics of cancer cell cultures to assess the effects of dietary phytochemicals

References

• Ackerstaff, E., Pflug, B. R., Nelson, J. B. and Bhujwalla, Z. M. (2001). Detection of increased choline compounds with proton nuclear magnetic resonance spectroscopy subsequent to malignant transformation of human prostatic epithelial cells. Cancer Res. 61:3599–3603.
   PubMed Web of Science ®Google Scholar
• Adams, S., Braidy, N., Bessede, A., Brew, B. J., Grant, R., Teo, C. and Guillemin, G. J. (2012). The kynurenine pathway in brain tumor pathogenesis. Cancer Res. 72:5649–5657.
   PubMed Web of Science ®Google Scholar
• Anso, E., Mullen, A. R., Felsher, D. W., Matés, J. M., Deberardinis, R. J. and Chandel, N. S. (2013). Metabolic changes in cancer cells upon suppression of MYC. Cancer Metab. 1:7.
   PubMedGoogle Scholar
• Banerjee, S., Bueso-Ramos, C. and Aggarwal, B. B. (2002). Suppression of 7,12-dimethylbenz(a) anthracene-induced mammary carcinogenesis in rats by resveratrol: Role of nuclear factor – kappaB, cyclooxygenase 2 and matrix metalloprotease 9. Cancer Res. 62:4945–4954.
   PubMed Web of Science ®Google Scholar
• Bathe, O. F., Shaykhutdinov, R., Kopciuk, K., Weljie, A. M., McKay, A., Sutherland, F. R., Dixon, E., Dunse, N., Sotiropoulos, D. and Vogel, H. J. (2011). Feasibility of identifying pancreatic cancer based on serum metabolomics. Cancer Epidemiol. Biomar. Prev. 20:140–147.
   PubMed Web of Science ®Google Scholar
• Bayet-Robert, M. and Morvan, D. (2013). Metabolomics reveals metabolic targets and biphasic responses in breast cancer cells treated by curcumin alone and in association with docetaxel. PLoS One. 8:e57971.
   PubMed Web of Science ®Google Scholar
• Bayet-Robert, M., Loiseau, D., Rio, P., Demidem, A., Barthomeuf, C., Stepien, G. and Morvan, D. (2010). Quantitative two-dimensional HRMAS 1H-NMR spectroscopy based metabolite profiling of human cancer cell lines and response to chemotherapy. Magn. Reson. Med. 63:1172–1183.
   PubMed Web of Science ®Google Scholar
• Ben Sellem, D., Elbayed, K., Neuville, A., Moussallieh, F. M., Lang-Averous, G., Piotto, M., Bellocq, J. P. and Namer, I. J. (2011). Metabolomic characterization of ovarian epithelial carcinomas by hrmas-NMR spectroscopy. J. Oncol. 2011:174019.
   PubMedGoogle Scholar
• Bensaad, K., Tsuruta, A., Selak, M. A., Vidal, M. N., Nakano, K., Bartrons, R., Gottlieb, E. and Vousden, K. H. (2006). TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell. 126:107–120.
   Google Scholar
• Bishayee, A. (2009). Cancer prevention and treatment with resveratrol: From rodent studies to clinical trials. Cancer Prev. Res. (Phila). 2:409–418.
   PubMed Web of Science ®Google Scholar
• Bu, Q., Huang, Y., Yan, G., Cen, X. and Zhao, Y. L. (2012). Metabolomics: A revolution for novel cancer marker identification. Comb. Chem. High Throughput Screen. 15:266–275.
   PubMed Web of Science ®Google Scholar
• Cairns, R. A., Harris, I. S. and Mak, T. W. (2011). Regulation of cancer cell metabolism. Nat. Rev. Cancer. 1:85–95.
   Web of Science ®Google Scholar
• Cao, M., Zhao, L., Chen, H., Xue, W. and Lin, D. (2012). NMR-based metabolomic analysis of human bladder cancer. Anal. Sci. 28:451–456.
   PubMed Web of Science ®Google Scholar
• Cardaci, S. and Ciriolo, M. R. (2012). TCA cycle defects and cancer: When metabolism tunes redox state. Int. J. Cell Biol. 2012:161837.
   PubMedGoogle Scholar
• Carrola, J., Rocha, C. M., Barros, A. S., Gil, A. M., Goodfellow, B. K., Carreira, I. M., Bernardo, J., Gomes, A., Sousa, S., Carvalho, L. and Duarte, I. F. (2011). Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of urine. J. Proteome Res. 10:221–230.
   PubMed Web of Science ®Google Scholar
• Chattopadhyay, I., Biswas, K., Bandyopadhyay, U. and Banerjee, R. K. (2004). Turmeric and curcumin biological actions and medicinal applications. Curr. Sci. 87:44–50.
   Web of Science ®Google Scholar
• Chimento, A., Sala, M., Gomez-Monterrey, I. M., Musella, S., Bertamino, A., Caruso, A., Sinicropi, M. S., Sirianni, R., Puoci, F., Parisi, O. I., Campana, C., Martire, E., Novellino, E., Saturnino, C., Campiglia, P. and Pezzi, V. (2013). Biological activity of 3-chloro-azetidin-2-one derivatives having interesting antiproliferative activity on human breast cancer cell lines. Bioorg. Med. Chem. Lett. 23:6401–6405.
   PubMed Web of Science ®Google Scholar
• Choi, J. S., Chun, K. S., Kundu, J. and Kundu, J. K. (2013). Biochemical basis of cancer chemoprevention and/or chemotherapy with ginsenosides (review). Int. J. Mol. Med. 32:1227–1238.
   PubMed Web of Science ®Google Scholar
• Choudhuri, T., Pal, S., Agwarwal, M. L., Das, T. and Sa, G. (2002). Curcumin induces apoptosis in human breast cancer cells through p53-dependent Bax induction. FEBS Lett. 512:334–340.
   PubMed Web of Science ®Google Scholar
• Chun, E., Chan, Y., Koon Koh, P., Mal, M., Yean Cheah, P., Weng Eu, K., Backshall, A., Cavill, R., Nicholson, J. K. and Keun, H. C. (2009). Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS). J. Proteome Res. 8:352–361.
   PubMed Web of Science ®Google Scholar
• Cragg, G. M., Grothaus, P. G. and Newman, D. J. (2014). New horizons for old drugs and drug leads. J. Nat. Prod. 77:703–723.
   PubMed Web of Science ®Google Scholar
• Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., Marks, K. M., Prins, R. M., Ward, P. S., Yen, K. E., Liau, L. M., Rabinowitz, J. D., Cantley, L. C., Thompson, C. B., Vander Heiden, M. G. and Su, S. M. (2010). Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature. 465:966.
   PubMed Web of Science ®Google Scholar
• DeBerardinis, R. J. and Thompson, C. B. (2012). Cellular metabolism and disease: What do metabolic outliers teach us? Cell. 148:1132–1144.
   PubMed Web of Science ®Google Scholar
• Deng, C. X. (2009). SIRT1, is it a tumor promoter or tumor suppressor? Int. J. Biol. Sci. 5:147–152.
   PubMed Web of Science ®Google Scholar
• Farshidfar, F., Weljie, A. M., Kopciuk, K., Buie, W. D., Maclean, A., Dixon, E., Sutherland, F. R., Molckovsky, A., Vogel, H. J. and Bathe, O. F. (2012). Serum metabolomic profile as a means to distinguish stage of colorectal cancer. Genome Med. 4:42.
   PubMed Web of Science ®Google Scholar
• Gao, P.. Tchernyshyov, I., Chang, T. C., Lee, Y. S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T. and Dang, C. V. (2009). c-MYC suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature. 458:762–765.
   PubMed Web of Science ®Google Scholar
• Gerner, E. W. and Meyskens, F. L. Jr. (2004). Polyamines and cancer: Old molecules, new understanding. Nat. Rev. Cancer. 4:781–792.
   PubMed Web of Science ®Google Scholar
• Glunde, K., Jie, C. and Bhujwalla, Z. M. (2004). Molecular causes of the aberrant choline phospholipid metabolism in breast cancer. Cancer Res. 64:4270–4276.
   PubMed Web of Science ®Google Scholar
• Gruenbacher, G. and Thurnher, M. (2015). Mevalonate metabolism in cancer. Cancer Lett. 356:192–196.
   PubMed Web of Science ®Google Scholar
• Han, S. S., Seo, H. J. and Surh, Y. J. (2002). Curcumin suppresses activation of NF-kappaB and AP-1 induced by phorbol ester in cultured human promyelocytic leukemia cells. J. Biochem. Mol. Biol. 35:337–342.
   PubMedGoogle Scholar
• Hanahan, D. and Weinberg, R. A. (2000). The hallmarks of cancer. Cell. 100:57–70.
   PubMed Web of Science ®Google Scholar
• Hanahan, D. and Weinberg, R. A. (2011). Hallmarks of cancer: the next generation. Cell. 144:646–674.
   PubMed Web of Science ®Google Scholar
• Hardie, D. G. (2013). AMPK: A target for drugs and natural products with effects on both diabetes and cancer. Diabetes. 62:2164–2172.
   PubMed Web of Science ®Google Scholar
• Hasim, A., Ma, H., Mamtimin, B., Abudula, A., Niyaz, M., Zhang, L. W., Anwer, J. and Sheyhidin, I. (2012). Revealing the metabonomic variation of EC using 1H-NMR spectroscopy and its association with the clinicopathological characteristics. Mol. Biol. Rep. 39:8955–8964.
   PubMed Web of Science ®Google Scholar
• Hayes, D. P. (2007). Nutritional hormesis. Eur. J. Clin. Nutr. 61:147–159.
   PubMed Web of Science ®Google Scholar
• Hensley, C. T., Wasti, A. T. and DeBerardinis, R. J. (2013). Glutamine and cancer: Cell biology, physiology, and clinical opportunities. J. Clin. Invest. 123:3678–3684.
   PubMed Web of Science ®Google Scholar
• Hong, J., Bose, M., Ju, J., Ryu, J. H., Chen, X., Sang, S., Lee, M. J. and Yang, C. S. (2004). Modulation of arachidonic acid metabolism by curcumin and related beta-diketone derivatives: effects on cytosolic phospholipase A(2), cyclooxygenases and 5-lipoxygenase. Carcinogenesis. 25:1671–1679.
   PubMed Web of Science ®Google Scholar
• Igarashi, K. and Kashiwagi, K. (2010). Modulation of cellular function by polyamines. Int. J. Biochem. Cell Biol. 42:39–51.
   PubMed Web of Science ®Google Scholar
• Jäger, W., Gruber, A., Giessrigl, B., Krupitza, G., Szekeres, T. and Sonntag, D. (2011). Metabolomic analysis of resveratrol-induced effects in the human breast cancer cell lines MCF-7 and MDA-MB-231. OMICS. 15:9–14.
   PubMed Web of Science ®Google Scholar
• Jansen, J. J., Hoefsloot, H. C., Van der Greef, J., Timmerman, M. E., Westerhuis, J. A. and Smilde, A. K. (2005). ASCA: Analysis of multivariate data obtained from an experimental design. J Chemom. 19:469–481.
   Web of Science ®Google Scholar
• Khanduja, K. L., Bhardwaj, A. and Kaushik, G. (2004). Resveratrol inhibits N-nitrosodiethylamine-induced ornithine decarboxylase and cyclooxygenase in mice. J. Nutr. Sci. Vitaminol. 50:61–65.
   PubMed Web of Science ®Google Scholar
• Kok, T. M., Breda, S. G. and Briedé, J. J. (2012). Genomics-based identification of molecular mechanisms behind the cancer preventive action of phytochemicals: Potential and challenges. Curr. Pharm. Biotechnol. 13:255–264.
   PubMed Web of Science ®Google Scholar
• Kueck, A., Opipari, A. W. Jr., Griffith, K. A., Tan, L., Choi, M., Huang, J., Wahl, H. and Liu, J. R. (2007). Resveratrol inhibits glucose metabolism in human ovarian cancer cells. Gynecol. Oncol. 107:450–457.
   PubMed Web of Science ®Google Scholar
• Kuo, P. L., Chiang, L. C. and Lin, C. C. (2002). Resveratrol-induced apoptosis is mediated by p53-dependent pathway in Hep G2 cells. Life Sci. 72:23–34.
   PubMed Web of Science ®Google Scholar
• Kushi, L. H., Doyle, C., McCullough, M., Rock, C. L., Demark-Wahnefried, W., Bandera, E. V., Gapstur, S., Patel, A. V., Andrews, K., Gansler, T. and American Cancer Society 2010Nutrition and Physical Activity Guidelines Advisory Committee. (2012, Jan–Feb). American Cancer Society Guidelines on nutrition and physical activity for cancer prevention: Reducing the risk of cancer with healthy food choices and physical activity. CA Cancer. J. Clin. 62:30–67. doi:10.3322/caac.20140.
   Web of Science ®Google Scholar
• Lee, J. H., Khor, T. O., Shu, L., Su, Z. Y., Fuentes, F. and Kong, A. N. (2013). Dietary phytochemicals and cancer prevention: Nrf2 signaling, epigenetics and cell death mechanisms in blocking cancer initiation and progression. Pharmacol. Ther. 137:153–171.
   PubMed Web of Science ®Google Scholar
• Lee, P., Vousden, K. H. and Cheung, E. C. (2014). TIGAR, TIGAR, burning bright. Cancer Metab. 2:1.
   PubMedGoogle Scholar
• Lee, Y. K., Park, S. Y., Kim, Y. M. and Park, O. J. (2009). Regulatory effect of the AMPK COX-2 signaling pathway in curcumin-induced apoptosis in HT-29 coloncancer cells. Ann. NY Acad. Sci. 1171:489–494.
   PubMed Web of Science ®Google Scholar
• Lin, H. Y., Shih, A., Davis, F. B., Tang, H. Y., Martino, L. J., Bennett, JA. and Davis, P. J. (2002). Resveratrol-induced serine phosphorylation of p53 causes apoptosis in a mutant p53 prostate cancer cell line. J. Urol. 168:748–755.
   PubMed Web of Science ®Google Scholar
• Lin, H. Y., Sun, M., Tang, H. Y., Simone, T. M., Wu, Y. H., Grandis, J. R., Cao, H. J., Davis, P. J. and Davis, F. B. (2008). Resveratrol causes COX-2- and p53-dependent apoptosis in head and neck squamous cell cancer cells. J. Cell. Biochem. 104:2131–2142.
   PubMed Web of Science ®Google Scholar
• Linsalata, M. and Russo, F. (2008). Nutritional factors and polyamine metabolism in colorectal cancer. Nutrition. 24:382–389.
   PubMed Web of Science ®Google Scholar
• Liu, R. H. (2004). Potentially synergy of phytochemicals in cancer prevention: mechanisms of action. J. Nutr. 134:3479S–3485S.
   PubMed Web of Science ®Google Scholar
• Liu, R. H. (2013a). Dietary bioactive compounds and their health implications. J. Food. Sci. 78: A18–25.
   PubMed Web of Science ®Google Scholar
• Liu, R. H. (2013b). Health-promoting components of fruits and vegetables in the diet. Adv. Nutr. 4:384S–392S.
   PubMed Web of Science ®Google Scholar
• Malhotra, A., Nair, P. and Dhawan, D. K. (2014). Study to evaluate molecular mechanics behind synergistic chemo-preventive effects of curcumin and resveratrol during lung carcinogenesis. PLoS One. 9:e93820.
   PubMed Web of Science ®Google Scholar
• Massimi, M., Tomassini, A., Sciubba, F., Sobolev, A. P., Devirgiliis, L. C. and Miccheli, A. (2012). Effects of resveratrol on HepG2 cells as revealed by (1)H-NMR-based metabolic profiling. Biochim. Biophys. Acta. 1820:1–8.
   PubMed Web of Science ®Google Scholar
• Mazurek, S. and Eigenbrodt, E. (2003). The tumor metabolome. Anticancer Res. 23:1149–1154.
   PubMed Web of Science ®Google Scholar
• McGhie, T. K. and Rowan, D. D. (2012). Metabolomics for measuring phytochemicals, and assessing human and animal responses to phytochemicals in food science. Mol. Nutr. Food Res. 5:47–58.
   Google Scholar
• Miccheli, A., Tomassini, A., Puccetti, C., Valerio, M., Peluso, G., Tuccillo, F., Calvani, M., Manetti, C. and Conti, F. (2006). Metabolic profiling by 13C-NMR spectroscopy: [1,2-13C2] Glucose reveals a heterogeneous metabolism in human leukemia T cells. Biochimie. 88:437–448.
   PubMed Web of Science ®Google Scholar
• Miloso, M., Bertelli, A. A., Nicolini, G. and Tredici, G. (1999). Resveratrol-induced activation of the mitogen-activated protein kinases, ERK1 and ERK2, in human neuroblastoma SH-SY5Y cells. Neurosci. Lett. 264:141–144.
   PubMed Web of Science ®Google Scholar
• Morvan D. (2013). Functional metabolomics uncovers metabolic alterations associated to severe oxidative stress in MCF7 breast cancer cells exposed to ascididemin. Mar. Drugs. 11:3846–3860.
   PubMed Web of Science ®Google Scholar
• Murias, M., Handler, N., Erker, T., Pleban, K., Ecker, G., Saiko, P., Szekeres, T. and Jäger, W. (2004). Resveratrol analogues as selective cyclooxygenase-2 inhibitors: synthesis and structure–activity relationship. Bioorg. Med. Chem. 12:5571–5578.
   PubMed Web of Science ®Google Scholar
• Nazarewicz, R. R., Zenebe, W. J., Parihar, A., Parihar, M. S., Vaccaro, M., Rink, C., Sen, C. K. and Ghafourifar, P. (2007). 12(S)-hydroperoxyeicosatetraenoic acid (12-HETE) increases mitochondrial nitric oxide by increasing intramitochondrial calcium. Arch. Biochem. Biophys. 468:114–120.
   PubMed Web of Science ®Google Scholar
• Nguyen, T. H., Mustafa, F. B., Pervaiz, S., Ng, F. S. and Lim, L. H. (2008). ERK1/2 activation is required for resveratrol-induced apoptosis in MDA-MB-231 cells. Int. J. Oncol. 33:81–92.
   PubMed Web of Science ®Google Scholar
• Nicholson, J. K., Lindon, J. C. and Holmes, E. (1999). “Metabonomics”: Understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica. 29:1181–1189.
   PubMed Web of Science ®Google Scholar
• Pollard, P. J., Brière, J. J., Alam, N. A., Barwell, J., Barclay, E., Wortham, N. C., Hunt, T., Mitchell, M., Olpin, S., Moat, S. J., Hargreaves, I. P., Heales, S. J., Chung, Y. L., Griffiths, J. R., Dalgleish, A., McGrath, J. A., Gleeson, M. J., Hodgson, S. V., Poulsom, R., Rustin, P. and Tomlinson, I. P. (2005). Accumulation of Krebs cycle intermediates and over-expression of HIF1 alpha in tumours which result from germline FH and SDH mutations. Hum. Mol. Genet. 14:2231–2239.
   PubMed Web of Science ®Google Scholar
• Renaud, S. and De Lorgeril, M. W. (1992). Alcohol, platelets, and the French paradox for coronary heart disease. Lancet. 339:1523–1526.
   PubMed Web of Science ®Google Scholar
• Saddoughi, S. A., Song, P. and Ogretmen, B. (2008). Roles of bioactive sphingolipids and cancer biology and therapeutics. Subcell. Biochem. 49:413–440.
   PubMedGoogle Scholar
• Sarbassov, D. D., Ali, S. M. and Sabatini, D. M. (2005). Growing roles for the mTOR pathway. Curr. Opin. Cell Biol. 17:596–603.
   PubMed Web of Science ®Google Scholar
• Schulze, A. and Harris, A. L. (2012). How cancer metabolism is tunes for proliferation and vulnerable to disruption. Nature. 491:364–373.
   PubMed Web of Science ®Google Scholar
• Seyfried, T. N. and Shelton, L. M. (2010). Cancer as a metabolic disease. Nutr. Metab. (Lond). 7:7.
   PubMed Web of Science ®Google Scholar
• Seyfried, T. N., Flores, R. E., Poff, A. M. and D'Agostino, D. P. (2014). Cancer as a metabolic disease: Implications for novel therapeutics. Carcinogenesis. 35:515–527.
   PubMed Web of Science ®Google Scholar
• Shishodia, S., Singh, T. and Chaturvedi, M. M. (2007). Modulation of transcription factors by curcumin. Adv. Exp. Med. Biol. 595:127–148.
   PubMed Web of Science ®Google Scholar
• Slavin, J. L. and Lloyd, B. (2012). Health benefits of fruits and vegetables. Adv. Nutr. 3:506–516.
   PubMed Web of Science ®Google Scholar
• Smilde, A. K., Jansen, J. J., Hoefsloot, H. C., Lamers, R. J., Van der Greef J. and Timmerman, M. E. (2005). ANOVA-simultaneous component analysis (ASCA): A new tool for analyzing designed metabolomics data. Bioinformatics. 21:3043–3048.
   PubMed Web of Science ®Google Scholar
• Smith, R. J. (2013). Nutrition and metabolism in hepatocellular carcinoma. Hepatobiliary Surg. Nutr. 2:89–96.
   PubMedGoogle Scholar
• Son, T. G., Camandola, S. and Mattson, M. P. (2008). Hormetic dietary phytochemicals. Neuromolecular Med. 1:236–246.
   Web of Science ®Google Scholar
• Sui, X., Jin, L., Huang, X., Geng, S., He, C. and Hu, X. (2011). p53 Signaling and autophagy in cancer: A revolutionary strategy could be developed for cancer treatment. Autophagy. 7:565–571.
   PubMed Web of Science ®Google Scholar
• Surh, Y. J. (2003). Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer. 3:768–780.
   PubMed Web of Science ®Google Scholar
• Takao, K., Rickhag, M., Hegardt, C., Oredsson, S. and Persson, L. (2006). Induction of apoptotic cell death by putrescine. Int. J. Biochem. Cell. Biol. 38:621–628.
   PubMed Web of Science ®Google Scholar
• Takaoka, M. (1940). The phenolic substances of white hellebore (Veratrum Grandiflorum Loes. Fill). V. Nippon Kagaku Kaishi 61:1067–1069.
   Google Scholar
• Tang, H. Y., Shih, A., Cao, H. J., Davis, F. B., Davis, P. J. and Lin, H. Y. (2006). Resveratrol-induced cyclooxygenase-2 facilitates p53-dependent apoptosis in human breast cancer cells. Mol. Cancer Ther. 5:2034–2042.
   PubMed Web of Science ®Google Scholar
• Teahan, O., Bevan, C. L., Waxman, J. and Keun, H. C. (2011). Metabolic signatures of malignant progression in prostate epithelial cells. Int. J. Biochem. Cell. Biol. 43:1002–1009.
   PubMed Web of Science ®Google Scholar
• Thakur, V. S., Deb, G., Babcook, M. A. and Gupta, S. (2014). Plant phytochemicals as epigenetic modulators: Role in cancer chemoprevention. AAPS J. 16:151–163.
   PubMed Web of Science ®Google Scholar
• Thompson, C. B. (2009). Metabolic enzymes as oncogenesor tumor suppressors. N. Engl. J. Med. 360:813–815.
   PubMed Web of Science ®Google Scholar
• Tiziani, S., Lopes, L. and Günther, U. L. (2009). Early stage diagnosis of oral cancer using 1H NMR-based metabolomics. Neoplasia. 11:269–276.
   PubMed Web of Science ®Google Scholar
• Upadhyay, M., Samal, J., Kandpal, M., Singh, O. V. and Vivekanandan, P. (2013). The Warburg effect: Insights from the past decade. Pharmacol. Ther. 137:318–330.
   PubMed Web of Science ®Google Scholar
• Van der Woude, H., Gliszczyńska-Swigło, A., Struijs, K., Smeets, A., Alink, G. M. and Rietjens, I. M. (2003). Biphasic modulation of cell proliferation by quercetin at concentrations physiologically relevant in humans. Cancer Lett. 200:41–47.
   PubMed Web of Science ®Google Scholar
• Van Staveren, W. C., Solís, D. Y., Hébrant, A., Detours, V., Dumont, J. E. and Maenhaut, C. (2009). Human cancer cell lines: Experimental models for cancer cells in situ? For cancer stem cells? Biochim. Biophys. Acta. 1795:92–103.
   PubMed Web of Science ®Google Scholar
• Vander Heiden, M. G., Cantley, L. C. and Thompson, C. B. (2009). Understanding the warburg effect: The metabolic requirements of cell proliferation. Science. 324:1029–1033.
   PubMed Web of Science ®Google Scholar
• Vargo-Gogola, T. and Rosen, J. M. (2007). Modelling breast cancer: One size does not fit all. Nat. Rev. Cancer. 7:659–672.
   PubMed Web of Science ®Google Scholar
• Vermeersch, K. A. and Styczynski, M. P. (2013). Applications of metabolomics in cancer research. J. Carcinog. 12:9.
   PubMedGoogle Scholar
• Watson, J. L., Greenshields, A., Hill, R., Hilchie, A, Lee, P. W., Giacomantonio, C. A. and Hoskin, D. W. (2010). Curcumin-induced apoptosis in ovarian carcinoma cells is p53-independent and involves p38 mitogen-activated protein kinase activation and downregulation of Bcl-2 and survivin expression and Akt signaling. Mol. Carcinog. 49:13–24.
   PubMed Web of Science ®Google Scholar
• Weljie, A. M., Bondareva, A., Zang, P. and Jirik, F. R. (2011). 1H NMR metabolomics identification of markers of hypoxia-induced metabolic shifts in a breast cancer model system. J. Biomol. NMR. 49:185–193.
   PubMed Web of Science ®Google Scholar
• White, E. (2012). Deconvoluting the context-dependent role for autophagy in cancer. Nat. Rev. Cancer. 12:401–410.
   PubMed Web of Science ®Google Scholar
• Widlund, A. L, Baur, J. A. and Vang, O. (2013). mTOR: More targets of resveratrol? Expert Rev. Mol. Med. 15:e10.
   PubMed Web of Science ®Google Scholar
• Wilken, R., Veena, M. S., Wang, M. B. and Srivatsan, E. S. (2011). Curcumin: A review of anti-cancer properties and therapeutic activity in in head and neck squamous cell carcinoma. Mol. Cancer. 10:12.
   PubMed Web of Science ®Google Scholar
• Woo, J. H., Kim, Y. H., Choi, Y. J., Kim, D. G., Lee, K. S., Bae, J. H., Min, D. S., Chang, J. S., Jeong, Y. J., Lee, Y. H., Park, J. W. and Kwon, T. K. (2003). Molecular mechanisms of curcumin-induced cytotoxicity: Induction of apoptosis through generation of reactive oxygen species, down-regulation of Bcl-XL and IAP, the release of cytochrome c and inhibition of Akt. Carcinogenesis. 24:1199–1208.
   PubMed Web of Science ®Google Scholar
• Woodside, J. V., Young, I. S. and McKinley, M. C. (2013). Fruit and vegetable intake and risk of cardiovascular disease. Proc. Nutr. Soc. 72:399–406.
   PubMed Web of Science ®Google Scholar
• Yang, C., Harrison, C., Jin, E. S., Chuang, D. T., Sherry, A. D., Malloy, C. R., Merritt, M. E. and Deberardinis, R. J. (2014). Simultaneous steady-state and dynamic 13C NMR can differentiate alternative routes of pyruvate metabolism in living cancer cells. J. Biol. Chem. 289:6212–6224.
   PubMed Web of Science ®Google Scholar
• Yang, M., Soga, T. and Pollard, P. (2013). Oncometabolites: Linking altered metabolism with cancer. J. Clin. Invest. 123:3652–3658.
   PubMed Web of Science ®Google Scholar
• Yoshii, Y., Furukawa, T., Saga, T. and Fujibayashi, Y. (2015). Acetate/acetyl-CoA metabolism associated with cancer fatty acid synthesis: Overview and application. Cancer Lett. 356:211–216.
   PubMed Web of Science ®Google Scholar
• Zhang, Q., Tang, X., Lu, Q. Y., Zhang, Z. F., Brown, J. and Le, A.D. (2005). Resveratrol inhibits hypoxia-induced accumulation of hypoxia-inducible factor-1alpha and VEGF expression in human tongue squamous cell carcinoma and hepatoma cells. Mol. Cancer Ther. 4:1465–1474.
   PubMed Web of Science ®Google Scholar
• Zhang, Z., Tan, M., Xie, Z., Dai, L., Chen, Y. and Zhao, Y. (2010). Identification of lysine succinylation as a new posttranslational modification. Nat. Chem. Biol. 7:58–63.
   PubMed Web of Science ®Google Scholar
• Zheng, S., Yumei, F. and Chen, A. (2007). De novo synthesis of glutathione is a prerequisite for curcumin to inhibit hepatic stellate cell (HSC) activation. Free Radic. Biol. Med. 43:444–453.
   PubMed Web of Science ®Google Scholar
• Zhou, G. Z., Xu, S. L., Sun, G. C. and Chen, X. B. (2014). Novel curcumin analogue IHCH exhibits potent antiproliferative effects by inducing autophagy in A549 lung cancer cells. Mol. Med. Rep. 10:441–446.
   PubMed Web of Science ®Google Scholar